AbbVie Executive and Leadership Team

Hasan Kurt, the Chief Financial Officer, Integration Lead Allergan Aesthetics at AbbVie, manages the financial synergy between core operations and the medical aesthetics division. Overseeing fiscal integration, the Chief Financial Officer, Integration Lead Allergan Aesthetics ensures that resource allocation supports long-term growth in the aesthetics market. Hasan Kurt directs financial planning to optimize the performance of specialized product lines, ensuring alignment with the company's broader biopharmaceutical objectives. This role involves evaluating investment opportunities and managing budgetary frameworks to sustain innovation in medical aesthetics. By maintaining rigorous financial oversight, the Chief Financial Officer, Integration Lead Allergan Aesthetics facilitates the seamless incorporation of new assets into the existing portfolio. Kurt drives efficiency by identifying cost-saving measures and revenue-generating strategies within the aesthetics segment. Through strategic financial leadership, the Chief Financial Officer, Integration Lead Allergan Aesthetics supports the company's mission to deliver high-quality health solutions to patients globally.

Pinar Ceylan, the Director, Finance & Chief Financial Officer at AbbVie, oversees the financial health and strategic capital allocation of the organization. Managing fiscal operations, the Director, Finance & Chief Financial Officer ensures that the company maintains the necessary liquidity to fund intensive research and development in immunology and neuroscience. Pinar Ceylan directs financial reporting and compliance, providing the transparency required for sustainable growth. This role involves collaborating with other C-suite leaders to align financial goals with the company's mission of addressing complex medical challenges. By implementing robust financial controls, the Director, Finance & Chief Financial Officer mitigates risk while supporting the expansion of the product pipeline. Ceylan drives the development of long-term financial strategies that enable the delivery of innovative medicines to patients. Through precise management of corporate assets, the Director, Finance & Chief Financial Officer ensures that the company remains well-positioned to meet evolving global health demands.

Scott Reents, the Executive VP & Chief Financial Officer at AbbVie, directs the global financial strategy and capital structure of the biopharmaceutical enterprise. Overseeing fiscal performance, the Executive VP & Chief Financial Officer ensures that the company maintains the financial strength required to invest in high-impact research and development. Scott Reents manages investor relations and corporate financial planning to support the company's long-term growth objectives. This role involves collaborating with the Board and other executive leaders to align financial resources with the company's mission of addressing complex medical challenges. By implementing disciplined financial management, the Executive VP & Chief Financial Officer optimizes the allocation of capital across core therapeutic areas like immunology and oncology. Reents drives the development of financial policies that foster innovation and operational efficiency. Through strategic oversight of the company's financial health, the Executive VP & Chief Financial Officer enables the delivery of innovative medicines to patients globally.

Portia Chen, the Chief of Staff at AbbVie, coordinates executive workflows to ensure alignment with the company's biopharmaceutical mission. Managing high-level administrative priorities, the Chief of Staff facilitates communication across departments to streamline decision-making processes. Portia Chen optimizes organizational efficiency by bridging gaps between leadership and operational teams. This role involves monitoring progress on key therapeutic initiatives, including immunology and oncology, to maintain focus on patient-centric goals. By fostering collaboration among senior leaders, the Chief of Staff supports the execution of complex medical strategies. The position requires constant evaluation of internal processes to drive performance improvements. Through rigorous oversight of corporate objectives, the Chief of Staff ensures that resources remain directed toward discovering and delivering innovative medicines. Ultimately, Chen maintains the operational rhythm necessary for the company to address significant unmet medical needs on a global scale.

Mark Schacher, the Director, Data and Statistical Science and Chief of Staff at AbbVie, architects data-driven frameworks to accelerate drug development. Overseeing statistical integrity, the Director, Data and Statistical Science and Chief of Staff ensures that clinical research meets rigorous scientific standards. Mark Schacher integrates advanced analytics into the discovery process, enabling more precise identification of therapeutic targets in neuroscience and eye care. This leadership role involves managing cross-functional teams to translate complex datasets into actionable health solutions. By refining statistical methodologies, the Director, Data and Statistical Science and Chief of Staff enhances the reliability of clinical trials. Schacher drives the adoption of modern data technologies to support the company's commitment to improving patient outcomes. Through strategic alignment of data science with operational goals, the Director, Data and Statistical Science and Chief of Staff facilitates faster delivery of innovative medicines to patients facing chronic diseases.

Jenina Nuñez, the Chief of Staff, Intercontinental at AbbVie, directs strategic operations across diverse international markets. Managing regional priorities, the Chief of Staff, Intercontinental ensures that the company's biopharmaceutical portfolio reaches patients in complex global environments. Jenina Nuñez coordinates with local leadership to adapt medical solutions to specific regional health needs, particularly in medical aesthetics and specialty care. This role involves aligning intercontinental business units with the overarching corporate mission of addressing serious medical challenges. By streamlining communication between global headquarters and regional offices, the Chief of Staff, Intercontinental fosters consistent execution of commercial strategies. Nuñez monitors market trends to identify opportunities for expanding the reach of innovative therapies. Through effective management of cross-border initiatives, the Chief of Staff, Intercontinental supports the company's goal of improving quality of life for patients worldwide. Ultimately, Nuñez drives operational excellence across the international footprint.

Kailash Purohit, the Commercial Neuroscience Chief of Staff (US) at AbbVie, coordinates the commercial strategy for the company's neuroscience portfolio within the North American market. Overseeing operational execution, the Commercial Neuroscience Chief of Staff (US) ensures that innovative treatments for neurological conditions reach patients effectively. Kailash Purohit aligns sales and marketing efforts with clinical data to maximize the impact of neuroscience therapies. This role involves managing cross-functional teams to streamline the delivery of health solutions to healthcare providers. By monitoring market performance and patient needs, the Commercial Neuroscience Chief of Staff (US) supports the development of targeted commercial initiatives. Purohit drives collaboration between research and commercial units to ensure that scientific advancements translate into tangible patient benefits. Through strategic oversight of US operations, the Commercial Neuroscience Chief of Staff (US) facilitates the growth of the neuroscience division, ultimately helping patients manage life-altering neurological diseases.

Martin Hayes, the Global Neuroscience & Ophthalmology Research Chief of Staff at AbbVie, manages the operational framework for research initiatives in neuroscience and eye care. Overseeing the research pipeline, the Global Neuroscience & Ophthalmology Research Chief of Staff ensures that scientific teams remain focused on discovering breakthrough therapies for complex medical conditions. Martin Hayes coordinates resource allocation across global laboratories to accelerate the development of new medicines. This role involves facilitating communication between research scientists and clinical development teams to streamline the transition from discovery to patient trials. By optimizing research workflows, the Global Neuroscience & Ophthalmology Research Chief of Staff supports the company's commitment to addressing unmet medical needs in ophthalmology and neuroscience. Hayes drives the implementation of strategic research goals that align with the company's mission. Through rigorous management of scientific operations, the Global Neuroscience & Ophthalmology Research Chief of Staff enables the delivery of innovative health solutions.

Brian Szopinski, the Director, Clinical Operations & Chief of Staff at AbbVie, directs the execution of clinical trials to validate new therapeutic candidates. Overseeing clinical logistics, the Director, Clinical Operations & Chief of Staff ensures that research protocols are implemented efficiently across global sites. Brian Szopinski manages the coordination between clinical teams and regulatory bodies to maintain compliance and data integrity. This role involves optimizing trial designs to address complex medical challenges in immunology and oncology. By streamlining operational processes, the Director, Clinical Operations & Chief of Staff accelerates the timeline for bringing innovative medicines to market. Szopinski drives collaboration across departments to ensure that clinical operations support the company's overarching mission of improving patient outcomes. Through strategic oversight of trial management, the Director, Clinical Operations & Chief of Staff facilitates the development of life-altering therapies that address significant unmet medical needs for patients worldwide.

Sarah Kopecky-Bromberg, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff at AbbVie, architects long-term planning for development and operational workflows within specialty medicine. Overseeing strategic initiatives, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff ensures that development pipelines align with the company's mission to address serious medical needs. Sarah Kopecky-Bromberg coordinates cross-functional efforts to streamline the path from drug development to commercialization. This role involves analyzing market trends and operational data to refine the company's approach to specialty therapies. By fostering collaboration between development and operations teams, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff enhances the efficiency of the drug delivery process. Kopecky-Bromberg drives the implementation of strategic goals that support the company's commitment to improving patient quality of life. Through rigorous planning and operational oversight, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff facilitates the delivery of innovative health solutions.